SEC Form 4 · accession 0001127602-18-025368
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Saik
Officer — Chief Financial Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 15, 2018 · 7:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | — | Aug 14, 2018 | A | 82,999 | A | — | — | Common Stock | 82,999 | 82,999 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- F2These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- F3Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.